Pharma Focus Asia
KP - Choose our fully recyclable blister films

Radiopharm Theranostics Expands Supply Agreement With Terthera For Terbium-161 Isotope Use In Prostate Cancer

Friday, August 25, 2023

Radiopharm Theranostics announced an expanded agreement with TerThera to supply Terbium-161 (Tb-161) for treatment of advanced prostate cancer.

The supply arrangement spans an initial duration of three years, open to extension for an additional two years. The first agreement with TerThera was signed in April 2023 to use RAD 602 for brain cancer. Now, the plan is to enhance this by creating a second compound connected to Terbium-161.

Tb-161 exhibits remarkable preclinical outcomes when compared to Lu-177, potentially leading to increased absorbed doses within micrometastatic ailments while minimising renal toxicity. This innovative radiopharmaceutical holds promise as the pioneering KLK-based theranostic alternative for individuals grappling with progressive prostate cancer.

RAD 402, developed by Radiopharmaceuticals (Radiopharm), combines the Tb-161 isotope and a unique monoclonal antibody (mAb) to create a radiotherapeutic. This innovative treatment is designed to specifically target KLK3 expression. KLK3 is prominently found in prostate cancer cells but has minimal presence in healthy tissues. 

The Phase I clinical trial focused on evaluating the safety and efficacy of RAD 402 in patients with advanced prostate cancer will be scheduled during the second half of 2024.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoBora Pharmaceuticals - Free WhitepaperThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023
MasterControl - 6 Essential Features in an eQMS